Estrogen replacement therapy (ERT) is indicated for menopausal symptoms like hot flashes and osteoporosis prevention. While ERT has risks such as endometrial cancer, it is not linked to major cardiovascular events.
Area of Science:
Reproductive Endocrinology
Geriatric Medicine
Pharmacology
Background:
Postmenopausal hormone therapy, specifically estrogen replacement therapy (ERT), is widely used but requires careful consideration.
Established indications for ERT include managing hot flashes, vaginal atrophy, and preventing osteoporosis.
Potential benefits for cardiovascular disease, skin aging, and mental health remain less clear.
Purpose of the Study:
To review the established and potential indications for ERT in postmenopausal women.
To detail the known and suspected side effects associated with ERT.
To provide recommendations for the use of ERT and adjunctive therapies.
Main Methods:
Literature review and synthesis of existing studies on estrogen replacement therapy.
Analysis of data regarding established and suggested indications for ERT.
Evaluation of reported side effects and risks associated with ERT, including cardiovascular events and cancers.
Assessment of the role of progesterone in mitigating ERT risks.
Consideration of different administration routes and alternative treatments.
Main Results:
Established ERT indications: hot flashes, vaginal atrophy, osteoporosis prevention.